NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.83
-0.32 (-2.26%)
At close: Mar 3, 2026, 4:00 PM EST
14.03
+0.20 (1.45%)
Pre-market: Mar 4, 2026, 6:26 AM EST

NeuroPace Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
21.6913.4318.066.6119.19
Short-Term Investments
39.3739.3348.470.896.4
Cash & Short-Term Investments
61.0652.7666.4577.41115.58
Cash Growth
15.74%-20.61%-14.15%-33.03%203.54%
Accounts Receivable
14.6812.8512.317.487.09
Inventory
16.913.3811.219.717.82
Other Current Assets
1.442.352.743.112.32
Total Current Assets
94.0781.3492.7297.71132.82
Net Property, Plant & Equipment
11.2612.914.4115.90.6
Other Long-Term Assets
0.240.410.520.490.14
Total Assets
105.5794.65107.65114.11133.56
Accounts Payable
2.222.952.332.151.38
Accrued Expenses
13.349.7911.187.417.92
Current Portion of Leases
2.121.861.631.42-
Unearned Revenue
0.140.561.09--
Total Current Liabilities
17.8115.1616.2310.989.3
Long-Term Debt
58.8859.5356.9552.9149.85
Long-Term Leases
9.8411.9513.8115.44-
Other Long-Term Liabilities
----0.91
Total Long-Term Liabilities
68.7271.4870.7768.3550.76
Total Liabilities
86.5386.638779.3360.06
Common Stock
0.030.030.030.030.02
Additional Paid-in Capital
571.41538.93524.44506.71497.52
Accumulated Other Comprehensive Income
----1.11-0.27
Retained Earnings
-552.42-530.95-503.81-470.85-423.77
Total Common Shareholders' Equity
19.038.0120.6534.7873.5
Shareholders' Equity
19.038.0120.6534.7873.5
Total Liabilities & Equity
105.5794.65107.65114.11133.56
Total Debt
70.8473.3472.469.7749.85
Net Cash (Debt)
-9.78-20.58-5.947.6465.74
Net Cash Growth
----88.38%-
Net Cash Per Share
-0.30-0.71-0.230.313.96
Book Value
19.038.0120.6534.7873.5
Book Value Per Share
0.580.280.801.414.43
Tangible Book Value
19.038.0120.6534.7873.5
Tangible Book Value Per Share
0.580.280.801.414.43
Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q